Karl Sandström

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Squamous Cell Carcinoma

Protein Protein

Immune Response

Radiation Therapy

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Thorsteinn Astradsson, Felix Sellberg, Ylva Tiblom Ehrsson, Karl Sandström, Göran Laurell
Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to Treatment. International journal of molecular sciences 23 (11) (2022)